(Q42249125)

19 October 2017

title

Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection (English)

1 reference

19 October 2017

K Frenzel

1

1 reference

19 October 2017

J Lehmann

2

1 reference

19 October 2017

D H Krüger

3

1 reference

19 October 2017

L Martin-Parras

4

1 reference

19 October 2017

L Uharek

5

1 reference

19 October 2017

J Hofmann

6

1 reference

19 October 2017

publication date

15 December 2013

1 reference

Medical Microbiology and Immunology

19 October 2017

published in

1 reference

19 October 2017

volume

203

1 reference

19 October 2017

issue

2

1 reference

19 October 2017

page(s)

115-123

1 reference

How we treat cytomegalovirus in hematopoietic cell transplant recipients

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Management of CMV infections: recommendations from the infectious diseases working party of the EBMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Cytomegalovirus pneumonia in hematopoietic stem cell recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

CMV infections after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

High genotypic diversity and a novel variant of human cytomegalovirus revealed by combined UL33/UL55 genotyping with broad-range PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Human NK cells can control CMV infection in the absence of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Envelopment of human cytomegalovirus occurs by budding into Golgi-derived vacuole compartments positive for gB, Rab 3, trans-golgi network 46, and mannosidase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0321-2

Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H

21 January 2018

1 reference

12 December 2020

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

1 reference

12 December 2020

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

12 December 2020

Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children

1 reference

12 December 2020

CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.

1 reference

12 December 2020

Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis

1 reference

12 December 2020

Cytomegalovirus immune evasion.

1 reference

12 December 2020

Strain-specific neutralization of human cytomegalovirus isolates by human sera.

1 reference

12 December 2020

Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection

1 reference

12 December 2020

Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies

1 reference

12 December 2020

10.1007/S00430-013-0321-2

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ibxbxuuy6fes5ptmezz42kzo4i

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_ibxbxuuy6fes5ptmezz42kzo4i

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ibxbxuuy6fes5ptmezz42kzo4i

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/ibxbxuuy6fes5ptmezz42kzo4i

1 reference

30 July 2022